Aytu Biopharma (AYTU) Prepaid Assets (2011 - 2026)

Aytu Biopharma (AYTU) has reported Prepaid Assets for 15 consecutive years, with $8.7 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Prepaid Assets rose 16.17% year-over-year to $8.7 million in Q1 2026; TTM through Mar 2026 was $8.7 million, a 16.17% increase from a year earlier, with the FY2025 full-year figure at $5.6 million, up 10.61% from the prior year.
• Prepaid Assets was $8.7 million for Q1 2026 at Aytu Biopharma, up from $6.6 million in the prior quarter.
• Over five years, Prepaid Assets peaked at $71.1 million in Q2 2023 and troughed at $5.1 million in Q2 2024.
• A 5-year average of $17.8 million and a median of $7.9 million in 2022 frame the typical range for Prepaid Assets.
• Across the five-year window, Prepaid Assets soared 863.78% in 2023 and plunged 92.83% in 2024, its largest moves.
• Over 5 years, Prepaid Assets stood at $12.0 million in 2022, then plunged by 32.4% to $8.1 million in 2023, then surged by 677.95% to $63.1 million in 2024, then sank by 89.47% to $6.6 million in 2025, then jumped by 30.51% to $8.7 million in 2026.
• The last three Prepaid Assets figures came in at $8.7 million (Q1 2026), $6.6 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.